Furthermore, we showed that whatever their TET2 mutational status, tumor T cells from acute ATLL patients express less TET2 transcript than tumor cells from chronic patients and that, when all patients were considered, there is a strong positive correlation between the level of 5-hmc and the amount of TET2 transcript. The gene discussed is TET2; the disease is neoplasm.